Latest filing published 07 Jan 2013 for DENDREON CORP.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Gerardo Canet discloses dealings in 2 companies, chiefly Integramed America Inc and Dendreon Corp. The record holds 68 filings, for trades running from 3 January 2006 to 3 January 2013.
Both buying and selling appear: 3 purchases worth €44k, against 35 sales worth €3.2M. Sales outweigh purchases by €3.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 13 share grants and 16 option exercises.
A typical purchase (the median) is worth €4,020.
The newest entry dates from 7 January 2013: a share grant, in Dendreon Corp. The most recent open-market purchase was published on 2 August 2012, 5,196 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 59 declarations